Insider Monkey
Wells Fargo Raises Aflac (AFL) Target, Revises Earnings Outlook and Valuation Approach
📈
AI Sentiment
Highly Positive
8/10
- Home
- AFL
as of 03-02-2026 3:35pm EST
$113.55
+$0.33
+0.29%
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
| Founded: | 1955 | Country: | United States |
| Employees: | N/A | City: | COLUMBUS |
| Market Cap: | 58.6B | IPO Year: | 1994 |
| Target Price: | $111.00 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 6.82 | EPS Growth: | -29.18 |
| 52 Week Low/High: | $96.95 - $119.32 | Next Earning Date: | 05-06-2026 |
| Revenue: | $17,164,000,000 | Revenue Growth: | -9.31% |
| Revenue Growth (this year): | -0.55% | Revenue Growth (next year): | 1.58% |
| P/E Ratio: | 16.60 | Index: | |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
AI-Powered AFL Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 73.13%
73.13%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of AFLAC Incorporated (AFL)
BEAVER STEVEN KENT
Sell
EVP, CFO Aflac Japan
AFL Feb 20, 2026
Avg Cost/Share
$113.58
Shares
7,387
Total Value
$839,015.46
Owned After
40,526
SEC Form 4
Broden Max
Sell
Sr. EVP, CFO
AFL Feb 6, 2026
Avg Cost/Share
$117.67
Shares
13,000
Total Value
$1,529,645.00
Owned After
122,062
SEC Form 4
BEAVER STEVEN KENT
Sell
EVP, CFO Aflac Japan
AFL Dec 12, 2025
Avg Cost/Share
$109.53
Shares
5,492
Total Value
$601,520.09
Owned After
40,526
SEC Form 4
BEAVER STEVEN KENT
Sell
EVP, CFO Aflac Japan
AFL Dec 5, 2025
Avg Cost/Share
$109.26
Shares
3,452
Total Value
$377,165.87
Owned After
40,526
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BEAVER STEVEN KENT | AFL | EVP, CFO Aflac Japan | Feb 20, 2026 | Sell | $113.58 | 7,387 | $839,015.46 | 40,526 | |
| Broden Max | AFL | Sr. EVP, CFO | Feb 6, 2026 | Sell | $117.67 | 13,000 | $1,529,645.00 | 122,062 | |
| BEAVER STEVEN KENT | AFL | EVP, CFO Aflac Japan | Dec 12, 2025 | Sell | $109.53 | 5,492 | $601,520.09 | 40,526 | |
| BEAVER STEVEN KENT | AFL | EVP, CFO Aflac Japan | Dec 5, 2025 | Sell | $109.26 | 3,452 | $377,165.87 | 40,526 |
Latest AFLAC Incorporated News
AFL Breaking Stock News: Dive into AFL Ticker-Specific Updates for Smart Investing
StockStory
Q4 Rundown: Aflac (NYSE:AFL) Vs Other Life Insurance Stocks
âž–
AI Sentiment
Neutral
4/10
Simply Wall St.
Is It Time To Reassess Aflac (AFL) After Its Recent Share Price Weakness?
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Wells Fargo Adjusts Price Target on Aflac to $118 From $109
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Aflac Insider Sold Shares Worth $839,015, According to a Recent SEC Filing
âž–
AI Sentiment
Neutral
4/10
Compare AFL vs Leading Stocks
See how AFL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AFL AFLAC Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.